Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hiatt

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pediatric Pulmonology|March 1, 1993
A lamb model for human respiratory syncytial virus infectionC D Lapin, P W Hiatt, C Langston, et al.
Pediatrics|June 2, 1998
Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectorsP A Piedra, G A Poveda, B Ramsey, et al.
The Pediatric Infectious Disease Journal|April 16, 1998
Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosisP A Piedra, S Grace, A Jewell, et al.
The Pediatric Infectious Disease Journal|January 1, 1996
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosisP A Piedra, S Grace, A Jewell, et al.
Pediatrics|March 2, 1999
Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosisP W Hiatt, S C Grace, C A Kozinetz, et al.
The European Respiratory Journal|June 2, 2012
Lung function from infancy to preschool in a cohort of children with cystic fibrosisLyndia C Brumback, Stephanie D Davis, Gwendolyn S Kerby, et al.
Chronobiology International|January 1, 1989
Day-night differences in steady-state theophylline pharmacokinetics in asthmatic childrenP H Scott, W G Kramer, M H Smolensky, et al.
Vaccine|May 15, 2003
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosisPedro A Piedra, Stanley G Cron, Alan Jewell, et al.
Journal of Clinical Microbiology|January 11, 2013
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strainRuth Ann Luna, Laura A Millecker, C Renee Webb, et al.
Pediatric Pulmonology|November 24, 2006
Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosisDaniel F Garcia, Peter W Hiatt, Alan Jewell, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pediatric Pulmonology|March 1, 1993
A lamb model for human respiratory syncytial virus infectionC D Lapin, P W Hiatt, C Langston, et al.
Pediatrics|June 2, 1998
Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectorsP A Piedra, G A Poveda, B Ramsey, et al.
The Pediatric Infectious Disease Journal|April 16, 1998
Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosisP A Piedra, S Grace, A Jewell, et al.
The Pediatric Infectious Disease Journal|January 1, 1996
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosisP A Piedra, S Grace, A Jewell, et al.
Pediatrics|March 2, 1999
Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosisP W Hiatt, S C Grace, C A Kozinetz, et al.
The European Respiratory Journal|June 2, 2012
Lung function from infancy to preschool in a cohort of children with cystic fibrosisLyndia C Brumback, Stephanie D Davis, Gwendolyn S Kerby, et al.
Chronobiology International|January 1, 1989
Day-night differences in steady-state theophylline pharmacokinetics in asthmatic childrenP H Scott, W G Kramer, M H Smolensky, et al.
Vaccine|May 15, 2003
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosisPedro A Piedra, Stanley G Cron, Alan Jewell, et al.
Journal of Clinical Microbiology|January 11, 2013
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strainRuth Ann Luna, Laura A Millecker, C Renee Webb, et al.
Pediatric Pulmonology|November 24, 2006
Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosisDaniel F Garcia, Peter W Hiatt, Alan Jewell, et al.
Pageof 3